Phase Ib/II study of biweekly TAS-102 with bevacizumab combination for patients with metastatic colorectal cancer refractory to standard therapies (BiTS study): Phase Ib results

Y. Kagawa, H. Satake, T. Kato, K. Oba, H. Yasui, M. Nakamura, T. Watanabe, K. Hirata, K. Muro, Y. Komatsu, T. Yoshino, K. Yamazaki, H. Mishima, M. Kotaka, A. Tsuji, Y. Kakeji, E. Oki, N. Nagata, S. Junichi

研究成果: Contribution to journalArticle査読

本文言語英語
ページ(範囲)ix34-ix35
ジャーナルAnnals of oncology : official journal of the European Society for Medical Oncology
29
DOI
出版ステータス出版済み - 11 1 2018

All Science Journal Classification (ASJC) codes

  • 血液学
  • 腫瘍学

引用スタイル